Apricus Biosciences (NASDAQ:APRI)
CAPS Rating:
A pharmaceutical and medical technology company, which conducts research and development both domestically and abroad on proprietary pharmaceutical products.
A pharmaceutical and medical technology company, which conducts research and development both domestically and abroad on proprietary pharmaceutical products.